PropertyValue
?:abstract
  • Exogenous surfactant therapy has been widely studied in acute respiratory distress syndrome (ARDS) but has failed to show mortality benefit in several ... »more»
?:creator
?:doi
?:doi
  • 10.1080/24745332.2020.1843202
?:externalLink
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/79b0502f96be5ee5268b89f6f2a2f3e8e2949f4e.json
?:pmcid
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • PMC
?:title
  • Considerations for the use and study of exogenous surfactant in respiratory disease from COVID-19
?:type
?:year
  • 2020-11-24

Metadata

Anon_0  
expand all